Key facts
- This page summarizes Louis C. Lucido's Form 4 filing for BioCorRx Inc. (BICX).
- 10 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 31 Jan 2025, 11:19.
Louis C. Lucido - 24 Apr 2024 Form 4 Insider Report for BioCorRx Inc. (BICX)
- Reporting relationship
- President, Director, 10%+ Owner
- Issuer ticker
- BICX
- Reported as of
- 24 Apr 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 31 Jan 2025, 11:19:44 UTC
- Prior SEC filing
- 03 Apr 2024
- Next SEC filing
- 01 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Louis C. Lucido
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Louis C. Lucido filed Form 4 for BioCorRx Inc. (BICX) on 31 Jan 2025.
Change
- Previous filing in this sequence was filed on 03 Apr 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BICX
transaction
Common Stock, par value $0.001
Other
- Transaction value
- $0
- Shares
- +460,477
- Change %
- +74%
- Price
- $0.000000
- Shares after
- 1,083,293
- Date
- 24 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +32,092
- Change %
- +3%
- Price
- $0.000000
- Shares after
- 1,115,385
- Date
- 31 Jul 2024
- Ownership
- Direct
- Footnotes
- F2
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +55,559
- Change %
- +5%
- Price
- $0.000000
- Shares after
- 1,170,944
- Date
- 30 Aug 2024
- Ownership
- Direct
- Footnotes
- F3
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +52,085
- Change %
- +4.4%
- Price
- $0.000000
- Shares after
- 1,223,029
- Date
- 30 Sep 2024
- Ownership
- Direct
- Footnotes
- F4
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +15,625
- Change %
- +1.3%
- Price
- $0.000000
- Shares after
- 1,238,654
- Date
- 30 Sep 2024
- Ownership
- Direct
- Footnotes
- F5
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +1,105,218
- Change %
- +89%
- Price
- $0.000000
- Shares after
- 2,343,872
- Date
- 14 Oct 2024
- Ownership
- Direct
- Footnotes
- F6
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +55,556
- Change %
- +2.4%
- Price
- $0.000000
- Shares after
- 2,399,428
- Date
- 31 Oct 2024
- Ownership
- Direct
- Footnotes
- F7
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +55,494
- Change %
- +2.3%
- Price
- $0.000000
- Shares after
- 2,454,922
- Date
- 29 Nov 2024
- Ownership
- Direct
- Footnotes
- F8
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +43,860
- Change %
- +1.8%
- Price
- $0.000000
- Shares after
- 2,498,782
- Date
- 31 Dec 2024
- Ownership
- Direct
- Footnotes
- F9
BICX
transaction
Common Stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +13,158
- Change %
- +0.53%
- Price
- $0.000000
- Shares after
- 2,511,940
- Date
- 31 Dec 2024
- Ownership
- Direct
- Footnotes
- F10
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 10 footnotes
Footnote F1
These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the "Company") and Mr. Lucido dated April 24, 2024 (the "April 2024 Exchange Agreement"). Pursuant to the April 2024 Exchange Agreement, Mr. Lucido agreed to the exchange of a promissory note then outstanding in the amount of $446,426 and the accrued interest on such promissory note of $7,858 and director fees of $90,000 for 460,477 shares of the Company's common stock, par value $0.001 per share (the "Common Stock") at a price of $1.18 per share based on the underlying value of the Common Stock at the date of issuance.
Footnote F2
These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.5193.
Footnote F3
These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.30.
Footnote F4
These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.32.
Footnote F5
These shares were issued to Mr. Lucido pursuant to a Director Agreement, dated March 1, 2019 (the "Director Agreement"), by and between the Company and Mr. Lucido. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares Common Stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.32.
Footnote F6
These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the "Company") and Mr. Lucido dated October 14, 2024 (the "October 2024 Exchange Agreement"). Pursuant to the October 2024 Exchange Agreement, Mr. Lucido agreed to the exchange the aggregate amount of $387,6700 of director's fees and loans to a subsidiary of the Company for 1,105,218 shares of Common Stock at a price of $0.36 per share based on the underlying value of the Common Stock at the date of issuance.
Footnote F7
These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.30.
Footnote F8
These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.31.
Footnote F9
These shares were issued to Mr. Lucido pursuant the Service Agreement. As compensation for his services under the Service Agreement, Mr. Lucido shall be issued, upon the last day of each month during the term of the Service Agreement, the number of shares Common Stock equivalent to $16,667 as determined based on the average closing price on the three trading days immediately preceding the last day of such month. The average closing price on the three trading days immediately preceding the date of this transaction was $0.38.
Footnote F10
These shares were issued to Mr. Lucido pursuant to the Director Agreement. As compensation for his services, Mr. Lucido shall be issued, upon the last day of each fiscal quarter, provided Mr. Lucido is a member of the Board as of such date, the number of shares Common Stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.38.